Back to Search
Start Over
Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells
- Source :
- Disease Models & Mechanisms, Disease Models & Mechanisms, Vol 9, Iss 4, Pp 451-462 (2016)
- Publication Year :
- 2016
- Publisher :
- The Company of Biologists Ltd, 2016.
-
Abstract
- X-linked dystonia-parkinsonism (XDP) is a hereditary neurodegenerative disorder involving a progressive loss of striatal medium spiny neurons. The mechanisms underlying neurodegeneration are not known, in part because there have been few cellular models available for studying the disease. The XDP haplotype consists of multiple sequence variations in a region of the X chromosome containing TAF1, a large gene with at least 38 exons, and a multiple transcript system (MTS) composed of five unconventional exons. A previous study identified an XDP-specific insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon in intron 32 of TAF1, as well as a neural-specific TAF1 isoform, N-TAF1, which showed decreased expression in post-mortem XDP brain compared with control tissue. Here, we generated XDP patient and control fibroblasts and induced pluripotent stem cells (iPSCs) in order to further probe cellular defects associated with this disease. As initial validation of the model, we compared expression of TAF1 and MTS transcripts in XDP versus control fibroblasts and iPSC-derived neural stem cells (NSCs). Compared with control cells, XDP fibroblasts exhibited decreased expression of TAF1 transcript fragments derived from exons 32-36, a region spanning the SVA insertion site. N-TAF1, which incorporates an alternative exon (exon 34′), was not expressed in fibroblasts, but was detectable in iPSC-differentiated NSCs at levels that were ∼threefold lower in XDP cells than in controls. These results support the previous findings that N-TAF1 expression is impaired in XDP, but additionally indicate that this aberrant transcription might occur in neural cells at relatively early stages of development that precede neurodegeneration.<br />Summary: This study describes a new iPSC model of X-linked dystonia-parkinsonism (XDP), which was initially validated by demonstrating a similar transcriptional defect as has been previously reported in XDP brain tissue.
- Subjects :
- 0301 basic medicine
Male
lcsh:Medicine
Medicine (miscellaneous)
Exon
0302 clinical medicine
Immunology and Microbiology (miscellaneous)
Neural Stem Cells
Induced pluripotent stem cell
Histone Acetyltransferases
Aged, 80 and over
Neurodegeneration
Brain
Genetic Diseases, X-Linked
Middle Aged
Neural stem cell
Dystonic Disorders
Female
X-linked dystonia-parkinsonism
lcsh:RB1-214
Gene isoform
Adult
Genetic Markers
Genotype
Induced Pluripotent Stem Cells
Neuroscience (miscellaneous)
Biology
General Biochemistry, Genetics and Molecular Biology
03 medical and health sciences
Cell Line, Tumor
lcsh:Pathology
medicine
TAF1
Humans
Resource Article
Amino Acid Sequence
RNA, Messenger
Aged
TATA-Binding Protein Associated Factors
lcsh:R
Alternative splicing
Intron
Fibroblasts
medicine.disease
Molecular biology
Alternative Splicing
030104 developmental biology
Haplotypes
Transcription Factor TFIID
030217 neurology & neurosurgery
Dystonic disorder
Subjects
Details
- Language :
- English
- ISSN :
- 17548411 and 17548403
- Volume :
- 9
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Disease Models & Mechanisms
- Accession number :
- edsair.doi.dedup.....292baf8766aee62237ab440e5f9d2204